Literature DB >> 27051507

Improving the physiological realism of experimental models.

Kalyan C Vinnakota1, Chae Y Cha2, Patrik Rorsman2, Robert S Balaban3, Andre La Gerche4, Richard Wade-Martins5, Daniel A Beard1, Jeroen A L Jeneson6.   

Abstract

The Virtual Physiological Human (VPH) project aims to develop integrative, explanatory and predictive computational models (C-Models) as numerical investigational tools to study disease, identify and design effective therapies and provide an in silico platform for drug screening. Ultimately, these models rely on the analysis and integration of experimental data. As such, the success of VPH depends on the availability of physiologically realistic experimental models (E-Models) of human organ function that can be parametrized to test the numerical models. Here, the current state of suitable E-models, ranging from in vitro non-human cell organelles to in vivo human organ systems, is discussed. Specifically, challenges and recent progress in improving the physiological realism of E-models that may benefit the VPH project are highlighted and discussed using examples from the field of research on cardiovascular disease, musculoskeletal disorders, diabetes and Parkinson's disease.

Entities:  

Keywords:  experimental models; human; physiology

Year:  2016        PMID: 27051507      PMCID: PMC4759746          DOI: 10.1098/rsfs.2015.0076

Source DB:  PubMed          Journal:  Interface Focus        ISSN: 2042-8898            Impact factor:   3.906


  105 in total

1.  The erythrocyte-perfused "working heart" model: hemodynamic and metabolic performance in comparison to crystalloid perfused hearts.

Authors:  B K Podesser; S Hallström; H Schima; L Huber; J Weisser; A Kröner; W Fürst; E Wolner
Journal:  J Pharmacol Toxicol Methods       Date:  1999-02       Impact factor: 1.950

2.  Optical measurements of intracellular oxygen concentration of rat heart in vitro.

Authors:  M Tamura; N Oshino; B Chance; I A Silver
Journal:  Arch Biochem Biophys       Date:  1978-11       Impact factor: 4.013

3.  Characterization of polyhormonal insulin-producing cells derived in vitro from human embryonic stem cells.

Authors:  Jennifer E Bruin; Suheda Erener; Javier Vela; Xiaoke Hu; James D Johnson; Harley T Kurata; Francis C Lynn; James M Piret; Ali Asadi; Alireza Rezania; Timothy J Kieffer
Journal:  Stem Cell Res       Date:  2013-10-16       Impact factor: 2.020

4.  Gamma-aminobutyric acid (GABA) is an autocrine excitatory transmitter in human pancreatic beta-cells.

Authors:  Matthias Braun; Reshma Ramracheya; Martin Bengtsson; Anne Clark; Jonathan N Walker; Paul R Johnson; Patrik Rorsman
Journal:  Diabetes       Date:  2010-04-22       Impact factor: 9.461

5.  Crystalloid and perfluorochemical perfusates in an isolated working rabbit heart preparation.

Authors:  J M Chemnitius; W Burger; R J Bing
Journal:  Am J Physiol       Date:  1985-08

6.  Noninvasive, nondestructive approaches to cell bioenergetics.

Authors:  B Chance; S Eleff; J S Leigh
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

Review 7.  Diabetes mellitus and the β cell: the last ten years.

Authors:  Frances M Ashcroft; Patrik Rorsman
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

8.  Mathematical modeling of heterogeneous electrophysiological responses in human β-cells.

Authors:  Michela Riz; Matthias Braun; Morten Gram Pedersen
Journal:  PLoS Comput Biol       Date:  2014-01-02       Impact factor: 4.475

9.  Strong inference for systems biology.

Authors:  Daniel A Beard; Martin J Kushmerick
Journal:  PLoS Comput Biol       Date:  2009-08-28       Impact factor: 4.475

10.  Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells.

Authors:  Mason A Israel; Shauna H Yuan; Cedric Bardy; Sol M Reyna; Yangling Mu; Cheryl Herrera; Michael P Hefferan; Sebastiaan Van Gorp; Kristopher L Nazor; Francesca S Boscolo; Christian T Carson; Louise C Laurent; Martin Marsala; Fred H Gage; Anne M Remes; Edward H Koo; Lawrence S B Goldstein
Journal:  Nature       Date:  2012-01-25       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.